Profile data is unavailable for this security.
About the company
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces innovative drugs, such as Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions.
- Revenue in HKD (TTM)7.10bn
- Net income in HKD767.83m
- Incorporated2015
- Employees7.03k
- LocationSimcere Pharmaceutical Group LtdNo. 699-18, Xuanwu Road, Xuanwu DistrictNANJING ChinaCHN
- Websitehttp://www.simcere.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yichang Hec Changjiang Pharmactcl Co Ltd | 6.76bn | 2.14bn | 7.88bn | 4.62k | 3.68 | 0.9249 | 3.27 | 1.17 | 2.43 | 2.43 | 7.68 | 9.69 | 0.5111 | 3.62 | 4.09 | 1,464,263.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 11.16 | 0.2475 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 8.26bn | 1.62k | -- | 2.11 | -- | 6.47 | -1.15 | -1.15 | 1.05 | 3.23 | -- | -- | -- | 785,492.10 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
Luye Pharma Group Ltd | 6.60bn | 572.15m | 10.61bn | 5.27k | 18.45 | 0.788 | 7.96 | 1.61 | 0.1529 | 0.1529 | 1.77 | 3.58 | 0.247 | 2.42 | 3.60 | 1,252,222.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
SciClone Pharmaceuticals (Holdings) Ltd | 3.39bn | 1.21bn | 11.80bn | 1.05k | 10.11 | 3.22 | 8.67 | 3.48 | 1.85 | 1.85 | 5.21 | 5.81 | 0.7585 | 3.56 | 3.83 | 3,228,498.00 | 26.97 | 27.09 | 33.34 | 36.32 | 74.67 | 76.06 | 35.55 | 35.43 | 4.50 | 33.70 | 0.01 | 22.98 | 14.76 | 17.50 | 31.16 | 15.96 | 25.65 | -- |
Shanghai Henlius Biotech Inc | 5.80bn | 586.56m | 12.42bn | 3.64k | 21.23 | 5.27 | 12.77 | 2.14 | 1.08 | 1.08 | 10.62 | 4.33 | 0.5731 | 1.95 | 9.10 | 1,593,481.00 | 5.80 | -8.59 | 12.47 | -14.14 | 72.64 | 71.77 | 10.12 | -27.37 | 0.3786 | 6.48 | 0.6512 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
SSY Group Ltd | 6.46bn | 1.32bn | 12.65bn | 5.60k | 9.62 | 1.82 | 7.23 | 1.96 | 0.4427 | 0.4427 | 2.17 | 2.33 | 0.5637 | 3.00 | 3.01 | 1,154,109.00 | 11.59 | 10.51 | 15.58 | 14.03 | 56.01 | 58.72 | 20.57 | 18.62 | 1.60 | 29.61 | 0.317 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
Zai Lab Ltd | 2.27bn | -2.65bn | 13.17bn | 2.18k | -- | 2.16 | -- | 5.79 | -2.73 | -2.73 | 2.35 | 6.12 | 0.2697 | 2.84 | 5.61 | -- | -31.41 | -37.72 | -36.81 | -42.72 | 62.86 | 64.75 | -116.45 | -282.44 | 4.43 | -- | 0.0596 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
Simcere Pharmaceutical Group Ltd | 7.10bn | 767.83m | 14.07bn | 7.03k | 19.20 | 1.86 | 12.79 | 1.98 | 0.288 | 0.288 | 2.72 | 2.97 | 0.6106 | 3.53 | 2.65 | 1,010,167.00 | 6.60 | 10.17 | 8.94 | 15.60 | 75.43 | 78.82 | 10.80 | 17.50 | 1.87 | 0.9742 | 0.1652 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
The United Laboratories Intl. Hldgs Ltd. | 14.76bn | 2.90bn | 15.06bn | 15.00k | 5.19 | 1.10 | 4.29 | 1.02 | 1.60 | 1.60 | 8.12 | 7.53 | 0.6871 | 3.36 | 6.15 | 984,005.60 | 13.51 | 7.89 | 20.52 | 12.64 | 46.11 | 44.17 | 19.66 | 12.73 | 1.74 | -- | 0.1055 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 46.04 |
3SBio Inc | 8.40bn | 1.66bn | 15.19bn | 5.41k | 9.45 | 1.01 | 7.36 | 1.81 | 0.6708 | 0.6708 | 3.44 | 6.29 | 0.3426 | 1.58 | 7.01 | 1,551,706.00 | 6.95 | 7.44 | 9.03 | 9.29 | 84.98 | 82.91 | 20.30 | 21.50 | 2.26 | 22.72 | 0.2266 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
China Medical System Holdings Ltd | 8.61bn | 2.58bn | 15.98bn | 5.70k | 6.23 | 0.9633 | 5.69 | 1.86 | 1.05 | 1.05 | 3.51 | 6.80 | 0.4517 | 3.42 | 6.19 | 1,509,960.00 | 13.44 | 18.44 | 15.70 | 21.14 | 76.24 | 75.47 | 29.76 | 34.26 | 3.98 | -- | 0.0772 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
Grand Pharmaceutical Group Ltd | 10.53bn | 1.88bn | 16.79bn | 10.53k | 8.83 | 1.09 | 7.34 | 1.59 | 0.5356 | 0.5356 | 3.00 | 4.33 | 0.4692 | 2.94 | 10.26 | 999,581.40 | 8.45 | 10.09 | 11.66 | 14.01 | 61.96 | 61.97 | 18.00 | 22.35 | 0.9819 | 22.96 | 0.1831 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
China Traditional Chinese Med Hldg CoLtd | 19.47bn | 1.38bn | 18.48bn | 17.30k | 13.39 | 0.813 | 6.88 | 0.9494 | 0.2742 | 0.2742 | 3.87 | 4.51 | 0.4985 | 1.47 | 2.16 | 1,125,090.00 | 3.84 | 4.60 | 5.85 | 7.07 | 51.18 | 57.07 | 7.70 | 9.77 | 1.48 | 9.83 | 0.1773 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
WuXi XDC Cayman Inc | 2.28bn | 304.59m | 19.10bn | 1.18k | 57.26 | 3.26 | 51.88 | 8.37 | 0.2784 | 0.2784 | 2.12 | 4.89 | -- | -- | -- | 1,936,789.00 | -- | -- | -- | -- | 26.35 | -- | 13.35 | -- | 4.03 | -- | 0.0005 | -- | 114.44 | -- | 82.07 | -- | -- | -- |
Data as of Jul 05 2024. Currency figures normalised to Simcere Pharmaceutical Group Ltd's reporting currency: Hong Kong Dollar HKD
5.53%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Norges Bank Investment Managementas of 31 Dec 2023 | 24.51m | 0.94% |
Principal Global Investors (Hong Kong) Ltd.as of 31 Dec 2023 | 18.91m | 0.72% |
The Vanguard Group, Inc.as of 06 Jun 2024 | 18.70m | 0.72% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 16.86m | 0.65% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 13.73m | 0.53% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 12.34m | 0.47% |
Dimensional Fund Advisors LPas of 06 Jun 2024 | 11.96m | 0.46% |
Essence Fund Co., Ltd.as of 31 Dec 2023 | 11.25m | 0.43% |
BlackRock Fund Advisorsas of 06 Jun 2024 | 8.17m | 0.31% |
HSBC Jintrust Fund Management Co. Ltd.as of 31 Dec 2023 | 7.82m | 0.30% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.